Novo Nordisk Faces Share Drop Amid Ozempic Vision Safety Concerns

Novo Nordisk's shares dropped over 2% after a preprint study linked Ozempic to a rare vision condition. The study, by scholars from Norway and Denmark, found Ozempic users were twi...